Study of Intracameral Adrenaline for Pupil Dilation Without Topical Mydriatics in Refractive Cataract Surgery

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01264653

Enrollment

Registered

2010-12-22

Start date

2010-12-31

Completion date

2011-12-31

Last updated

2012-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

cataract

Brief summary

The purpose of this study is to study the safety and efficacy of intracameral adrenaline for pupil dilation without topical mydriatics in refractive cataract surgery.

Interventions

DRUGadrenalin

adrenalin 0.01%

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

40 Years to 80 Years

Healthy volunteers

Inclusion criteria

* male and female * can read and sign informed consent form； * Clinical diagnosis of cataract * Cataract density grade II-III according to the Emery-Little system classification system

Exclusion criteria

* sensitivity to adrenalin； * sensitivity to topical mydriatics； * any other ocular surgeries； * iris abnormalities

Design outcomes

Primary

Measure	Time frame	Description
Pupil size after intracameral adrenaline	1day	We would like to evaluate Pupil size dilated with intracameral adrenaline 0.01%

Secondary

Measure	Time frame	Description
endothelial cell count	1month	we would like to evaluate the endothelial cell count 1 month after surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026